SCHEMBL2421772

SCHEMBL2421772

COc1cc(C=O)ccc1OCCN1CCCCC1

nearest known ligand 0.67

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.67
ACHE P22303 8/20 0.61
BCHE P06276 5/20 0.61
KDM4E B2RXH2 2/20 0.60
LTA4H P09960 1/20 0.60
POLB P06746 3/20 0.58
LMNA P02545 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MAPT P10636 2/20 0.55
HTT P42858 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
MEN1 O00255 1/20 0.54
GAA P10253 1/20 0.54
HPGD P15428 1/20 0.54
KMT2A Q03164 1/20 0.54
ALDH1A1 P00352 2/20 0.54
TSHR P16473 1/20 0.54
ALDH1A3 P47895 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30462846 1.00 FDPS (0.67) FDPSACHEBCHEKDM4ELTA4H
SCHEMBL2246767 0.99 FDPS (0.68) FDPSACHEBCHEKDM4ELTA4H
SCHEMBL30462823 0.99 FDPS (0.68) FDPSACHEBCHEKDM4ELTA4H
SCHEMBL30462820 0.94 ACHE (0.65) FDPSACHEBCHEKDM4E
SCHEMBL29038401 0.94 ACHE (0.65) FDPSACHEBCHEKDM4E
SCHEMBL29038397 0.93 FDPS (0.60) FDPSACHEBCHEKDM4ELTA4H
SCHEMBL30462827 0.92 FDPS (0.67) FDPSACHEBCHEKDM4ELMNA
SCHEMBL29038429 0.92 FDPS (0.67) FDPSACHEBCHEKDM4ELMNA
SCHEMBL28618325 0.90 FDPS (0.67) FDPSACHEBCHEKDM4ELTA4H
SCHEMBL29995386 0.90 FDPS (0.67) FDPSACHEBCHEKDM4ELTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116283936-A Substituted amino ether-containing 2, 2-dimethyl benzopyran derivative and salt or solvate thereof, preparation and application thereof, and composition 沈阳药科大学 2023-06-23 CN disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 US disclosed
WO-2010001169-A2 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 FDPS 1065/4885ACHE 2916/4885BCHE 3893/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 FDPS 1185/4885ACHE 2943/4885BCHE 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.